Ruszczak Z, Bienias L, Kaszuba A, Wiacek S, Bednarowicz G, Drobnik G, Prószyńska-Kuczyńska W, Ziaber B, Trznadel-Budźko E, Klimczak-Kapszewicz M
Katedry i Kliniki Dermatologicznej WAM w Lodzi.
Przegl Dermatol. 1990 Sep-Oct;77(5):336-40.
Tigason was applied in 51 patients with psoriasis and 19 with other skin diseases. In 18 patients was applied alone, in 42 combined with PUVA and in 10 with SUP. Roaccutan was applied in 18 patients with acne conglobata et phlegmonous resistant to other methods of treatment. Tigason was found to be a useful drug in psoriasis and some other skin diseases. The combination with PUVA or SUP allowed to reduce the doses of drugs and the dose of radiation. Roaccutan was found to be a useful drug in severe forms of acne vulgaris. The side effects of the treatment with retinoids were transient and they did not create danger to the patients.
银屑灵应用于51例银屑病患者和19例其他皮肤病患者。18例单独使用，42例与补骨脂素紫外线A光化学疗法（PUVA）联合使用，10例与系统性光化学疗法（SUP）联合使用。18例聚合性痤疮和硬结性痤疮患者对其他治疗方法耐药，使用了异维甲酸。发现银屑灵对银屑病和其他一些皮肤病是一种有用的药物。与PUVA或SUP联合使用可减少药物剂量和辐射剂量。发现异维甲酸对重度寻常痤疮是一种有用的药物。维甲酸治疗的副作用是短暂的，不会给患者带来危险。
